Hims & Hers Health (NYSE:HIMS) Shares Up 1.6%

Hims & Hers Health, Inc. (NYSE:HIMS) rose 1.6% during trading on Monday . The company traded as high as $16.65 and last traded at $16.21. Approximately 2,417,150 shares changed hands during mid-day trading, a decline of 69% from the average daily volume of 7,865,626 shares. The stock had previously closed at $15.96.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on HIMS shares. Imperial Capital cut shares of Hims & Hers Health from an “outperform” rating to an “in-line” rating in a report on Friday, August 9th. Bank of America increased their price target on shares of Hims & Hers Health from $22.00 to $26.00 and gave the company a “buy” rating in a research report on Thursday, June 13th. Seaport Res Ptn reissued a “buy” rating on shares of Hims & Hers Health in a research note on Friday, April 26th. TD Cowen increased their target price on Hims & Hers Health from $15.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, July 11th. Finally, Truist Financial boosted their price objective on shares of Hims & Hers Health from $13.00 to $23.00 and gave the company a “hold” rating in a research note on Thursday, July 18th. Eight equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat, Hims & Hers Health presently has an average rating of “Hold” and a consensus target price of $20.00.

Hims & Hers Health Stock Performance

The stock has a market capitalization of $3.31 billion, a PE ratio of -1,575.00 and a beta of 1.08. The firm has a 50 day moving average of $20.93 and a 200-day moving average of $16.11.

Hims & Hers Health (NYSE:HIMS) last posted its quarterly earnings results on Monday, August 5th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Hims & Hers Health had a negative net margin of 0.24% and a negative return on equity of 0.70%. The business had revenue of $315.65 million during the quarter, compared to analyst estimates of $302.43 million. During the same period in the prior year, the firm earned ($0.03) earnings per share. The firm’s revenue was up 51.8% compared to the same quarter last year. On average, sell-side analysts predict that Hims & Hers Health, Inc. will post 0.2 earnings per share for the current year.

Insider Activity

In other news, insider Soleil Boughton sold 2,334 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $17.30, for a total transaction of $40,378.20. Following the completion of the sale, the insider now directly owns 164,475 shares of the company’s stock, valued at approximately $2,845,417.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Hims & Hers Health news, insider Soleil Boughton sold 2,334 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $17.30, for a total transaction of $40,378.20. Following the transaction, the insider now directly owns 164,475 shares in the company, valued at $2,845,417.50. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Andrew Dudum sold 188,888 shares of the company’s stock in a transaction that occurred on Tuesday, June 4th. The stock was sold at an average price of $19.88, for a total value of $3,755,093.44. The disclosure for this sale can be found here. Insiders have sold a total of 974,404 shares of company stock worth $19,365,507 in the last ninety days. Corporate insiders own 17.71% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of HIMS. Allspring Global Investments Holdings LLC increased its holdings in shares of Hims & Hers Health by 103.2% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 43,662 shares of the company’s stock worth $389,000 after purchasing an additional 22,170 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Hims & Hers Health by 5.6% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,335 shares of the company’s stock valued at $261,000 after buying an additional 1,561 shares during the period. Russell Investments Group Ltd. boosted its stake in shares of Hims & Hers Health by 30.7% in the 4th quarter. Russell Investments Group Ltd. now owns 167,328 shares of the company’s stock valued at $1,489,000 after purchasing an additional 39,337 shares during the last quarter. Certuity LLC bought a new position in Hims & Hers Health in the fourth quarter valued at approximately $109,000. Finally, Oder Investment Management LLC acquired a new stake in shares of Hims & Hers Health during the fourth quarter worth $176,000. Institutional investors and hedge funds own 63.52% of the company’s stock.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.